- Personalized models of BeamF3 targeting in transcranial magnetic stimulation for depression: Implications for precision clinical translation. Rajasekharan D, Madore MR, Holtzheimer P, Lim KO, Williams LM, Philip NS. Brain Stimul. 2025 Apr 5:S1935-861X(25)00084-1. doi: 10.1016/j.brs.2025.04.003. PMID: 40194594
- Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial. Ober AJ, Murray-Krezan C, Page K, Friedmann PD, Anderson J, Osilla KC, Ryzewicz S, Huerta S, Mazer MW, Hoskinson RA, Garvey R, Peltz A, Watkins KE, Nuckols T, IsHak WW, Mariano LT, Danovitch I. JAMA Intern Med. 2025 Apr 7. doi: 10.1001/jamainternmed.2024.8586. PMID: 40193131
- Defining clinical course of patients evaluated for pediatric acute-onset neuropsychiatric syndrome (PANS): phenotypic classification based on 10 years of clinical data. Masterson EE, Miles K, Schlenk N, Manko C, Ma M, Farhadian B, Chang K, Silverman M, Thienemann M, Frankovich J. Dev Neurosci. 2025 Apr 4:1-33. doi: 10.1159/000545598. PMID: 40188825
- Stimulation mapping and whole-brain modeling reveal gradients of excitability and recurrence in cortical networks. Momi D, Wang Z, Parmigiani S, Mikulan E, Bastiaens SP, Oveisi MP, Kadak K, Gaglioti G, Waters AC, Hill S, Pigorini A, Keller CJ, Griffiths JD. Nat Commun. 2025 Apr 4;16(1):3222. doi: 10.1038/s41467-025-58187-6. PMID: 40185725
- Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trial. Lii TR, Flohr JR, Okada RL, Cianfichi LJ, Hack LM, Schatzberg AF, Heifets BD. J Affect Disord. 2025 Apr 2:S0165-0327(25)00560-9. doi: 10.1016/j.jad.2025.04.008. PMID: 40185412
- Implementation of an Organization-Based Couples Health Promotion Program to Improve Physician Well-Being. Gold JM, Shanafelt TD, Wang H, Townson J, Stolz S, Menon N, Trockel M. JAMA Netw Open. 2025 Apr 1;8(4):e253218. doi: 10.1001/jamanetworkopen.2025.3218. PMID: 40184067